Atlas Trials

Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma

RecordFirmDate
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma (NCT03409432)John Reneau2018-03-16
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma (NCT02232516)Northwestern University2015-06-11
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant (NCT01959477)Case Comprehensive Cancer Center2014-03-01
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT01800838)Kevin Cooper MD2013-04-01
Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma (NCT01738594)Northwestern University2013-03-22
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas (NCT01805037)Northwestern University2013-03-05
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015)City of Hope Medical Center2012-10-29
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies (NCT01273766)Wake Forest University Health Sciences2011-01-01
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562)City of Hope Medical Center2010-12-01
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (NCT01053494)Wake Forest University Health Sciences2010-04-01
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer (NCT01044745)University of Nebraska2009-12-10
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma (NCT00601718)University of Washington2007-12-01
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203)Fred Hutchinson Cancer Center2007-04-01
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer (NCT00089011)Fred Hutchinson Cancer Center2004-04-01
Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides (NCT00052377)National Cancer Institute (NCI)2002-09-01
506U78 in Treating Patients With Lymphoma (NCT00005080)National Cancer Institute (NCI)2000-05-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)Fred Hutchinson Cancer Center1999-11-01
O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma (NCT00003613)National Cancer Institute (NCI)1999-04-01

Track Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.